Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Articles related to Cumberland Pharmaceuticals


Cumberland Pharmaceuticals Adds Vibativ®
Cumberland Pharmaceuticals Adds Vibativ®

Cumberland Pharmaceuticals recently announced the addition of Vibativ® (telavancin) to its growing product lineup. The Nashville-headquartered specialty pharmaceutical company entered into a definitive agreement to acquire Vibativ from Theravance Biopharma in the fourth quarter of 2018.

more
ONcology Rounds
ONcology Rounds

News of note in cancer research, treatment and partnerships.

more
Cumberland Pharmaceuticals Launches Oncology Division
Cumberland Pharmaceuticals Launches Oncology Division

Nashville-based Cumberland Pharmaceuticals has announced expansion into oncology support with the launch of a new corporate division.

more
Cumberland Pharma Enters Agreement for Kristalose®

Nashville-based Cumberland Pharmaceuticals has entered a co-promotion agreement for Kristalose® within the United States with Poly Pharmaceuticals Inc., a privately held U.S. specialty pharmaceutical company.

more
From Clinical Trial to Commercialization
From Clinical Trial to Commercialization

The road to drug development and approval is long and expensive. Cumberland Pharmaceutical CEO A.J. Kazimi offers an inside look at the process.

more
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: